Donate Help Contact The AHA Sign In Home
American Heart Association
Circulation
Search: search_blue_button Advanced Search
Circulation. 1991;84:2504-2512

This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Right arrow Citation Map
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Permissions
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Miura, T.
Right arrow Articles by Iimura, O.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Miura, T.
Right arrow Articles by Iimura, O.

Circulation, Vol 84, 2504-2512, Copyright © 1991 by American Heart Association


ARTICLES

Does myocardial stunning contribute to infarct size limitation by ischemic preconditioning?

T Miura, M Goto, K Urabe, A Endoh, K Shimamoto and O Iimura
Second Department of Internal Medicine, Sapporo Medical College, Japan.

BACKGROUND. The mechanism through which ischemic preconditioning causes cardioprotection is unknown. The present study investigated the role of stunning in preconditioning. METHODS AND RESULTS. We studied three different protocols of preconditioning: two cycles of 2-minute ischemia separated by 5-minute reperfusion (2'PC), one cycle of 5-minute ischemia by 5-minute reperfusion (5'PC1), and two cycles of 5-minute ischemia separated by 5-minute reperfusion (5'PC2). In the first series of experiments, the stunning associated with 2'PC, 5'PC1, or 5'PC2 was assessed using an epicardial Doppler transducer in anesthetized open- chest rabbits. The thickening fraction (percent baseline) of the preconditioned region was 76.8 +/- 7.2% (mean +/- SEM) after 2'PC but 31.4 +/- 9.2% and 34.3 +/- 9.7% after 5'PC1 and 5'PC2, respectively, which were significantly lower, thus indicating more severe stunning than that after 2'PC. In the second series of experiments, a branch of the left circumflex artery was occluded for 30 minutes and then reperfused for 72 hours in four groups of rabbits. One group was not preconditioned and three groups were preconditioned with 2'PC, 5'PC1, or 5'PC2 protocols before the 30-minute ischemia. In contrast to the differences observed in the stunning in the first series of experiments, histological infarct size was similar in the three preconditioned groups (21.1 +/- 3.0% of area at risk after 2'PC, 20.1 +/- 3.4% after 5'PC1, 16.4 +/- 4.2% after 5'PC2), all of which were significantly smaller than that in the unpreconditioned group (43.9 +/- 5.0%). The third series of experiments examined the degree of stunning by 2'PC, 5'PC1, or 5'PC2 and the size of infarct (tetrazolium staining) in the same animal after 30-minute ischemia/3-hour reperfusion; again, the results showed no significant correlation between degree of stunning and infarct size. CONCLUSIONS. The myocardial infarct size- limiting effect of preconditioning did not correlate with the degree of myocardial stunning accompanying preconditioning. Thus, it is unlikely that myocardial stunning contributes to the cardioprotective effect of ischemic preconditioning.


This article has been cited by other articles:


Home page
Physiol. Rev.Home page
E. Murphy and C. Steenbergen
Mechanisms Underlying Acute Protection From Cardiac Ischemia-Reperfusion Injury
Physiol Rev, April 1, 2008; 88(2): 581 - 609.
[Abstract] [Full Text] [PDF]


Home page
J. Appl. Physiol.Home page
P. C. Beguin, M. Joyeux-Faure, D. Godin-Ribuot, P. Levy, and C. Ribuot
Acute intermittent hypoxia improves rat myocardium tolerance to ischemia
J Appl Physiol, September 1, 2005; 99(3): 1064 - 1069.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. A. Kloner and R. B. Jennings
Consequences of Brief Ischemia: Stunning, Preconditioning, and Their Clinical Implications: Part 2
Circulation, December 18, 2001; 104(25): 3158 - 3167.
[Abstract] [Full Text] [PDF]


Home page
CirculationHome page
R. A. Kloner and R. B. Jennings
Consequences of Brief Ischemia: Stunning, Preconditioning, and Their Clinical Implications: Part 1
Circulation, December 11, 2001; 104(24): 2981 - 2989.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Miura, Y. Liu, M. Goto, A. Tsuchida, T. Miki, A. Nakano, Y. Nishino, Y. Ohnuma, and K. Shimamoto
Mitochondrial ATP-sensitive K+ channels play a role in cardioprotection by Na+-H+ exchange inhibition against ischemia/reperfusion injury
J. Am. Coll. Cardiol., March 1, 2001; 37(3): 957 - 963.
[Abstract] [Full Text] [PDF]


Home page
J Am Coll CardiolHome page
T. Matsubara, S. Minatoguchi, H. Matsuo, K. Hayakawa, T. Segawa, Y. Matsuno, S. Watanabe, M. Arai, Y. Uno, M. Kawasaki, et al.
Three minute, but not one minute, ischemia and nicorandil have a preconditioning effect in patients with coronary artery disease
J. Am. Coll. Cardiol., February 1, 2000; 35(2): 345 - 351.
[Abstract] [Full Text] [PDF]


Home page
Cardiovasc ResHome page
J. M.J. Lamers
Preconditioning and limitation of stunning: one step closer to the protected protein(s)?
Cardiovasc Res, June 1, 1999; 42(3): 571 - 575.
[Full Text] [PDF]


Home page
Cardiovasc ResHome page
T. Miura, T. Miura, S. Kawamura, M. Goto, J. Sakamoto, A. Tsuchida, M. Matsuzaki, and K. Shimamoto
Effect of protein kinase C inhibitors on cardioprotection by ischemic preconditioning depends on the number of preconditioning episodes
Cardiovasc Res, March 1, 1998; 37(3): 700 - 709.
[Abstract] [Full Text] [PDF]


Home page
Ann. Thorac. Surg.Home page
J. L. Zellner, L. Hebbar, F. A. Crawford Jr, R. Mukherjee, and F. G. Spinale
Beneficial Effects of Myocyte Preconditioning on Contractile Processes After Cardioplegic Arrest
Ann. Thorac. Surg., February 1, 1996; 61(2): 558 - 564.
[Abstract] [Full Text]


Home page
J. Thorac. Cardiovasc. Surg.Home page
A. S. Abd-Elfattah, M. Ding, and A. S. Wechsler
INTERMITTENT AORTIC CROSSCLAMPING PREVENTS CUMULATIVE ADENOSINE TRIPHOSPHATE DEPLETION, VENTRICULAR FIBRILLATION, AND DYSFUNCTION (STUNNING): IS IT PRECONDITIONING?
J. Thorac. Cardiovasc. Surg., August 1, 1995; 110(2): 328 - 339.
[Abstract] [Full Text]